Ledger.Open graph →
SEC Form D · Amendment · filed May 19, 2017

Lung Therapeutics, Inc

Offering
$14.3M
Sold
$14.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Aaron B. Fletcher · Carrollton, TXDirectorSteven B. Idell · Tyler, TXDirectorRobert B. Mills · Naples, FLDirectorKathryn Stewart · LARKSPUR, CADirectorHamish Cameron · London, United KingdomDirectorCatherine Bingham · London, United KingdomDirectorJames B. Windsor · Austin, TXExec · DirectorMichael Ross · London, United KingdomDirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorJames B. Windsor · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗